2025-07-28 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB), incorporating the provided data, presented in an English report format with simplified explanations and numerical highlights:

## Albemarle Corp (ALB) Stock Analysis

**Ticker:** ALB
**Company Description:** Albemarle Corp is a specialty chemicals company that develops, manufactures, and markets engineered specialty chemicals.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 39.19%
*   **VOO (S&P 500) Cumulative Return:** 99.66%
*   **Absolute Divergence:** -59.0 (ALB trails VOO by 59.0 percentage points.)
*   **Relative Divergence:** 7.7 (ALB's performance is currently at the 7.7th percentile of its historical divergence range with VOO.)

**Analysis:**  ALB has significantly underperformed the S&P 500 over the period examined.  The Relative Divergence suggests ALB's underperformance is near the lower end of its historical range relative to the S&P 500.

#### Alpha and Beta Analysis:

| Year       | CAGR    | MDD     | Alpha   | Beta | Cap(B) |
|------------|---------|---------|---------|------|--------|
| 2015-2017  | 99.0%   | 8.1%    | 70.0%   | 0.0  | 15.1   |
| 2016-2018  | 13.0%   | 58.0%   | -5.0%   | 0.0  | 9.1    |
| 2017-2019  | -44.0%  | 58.0%   | -74.0%  | -0.0 | 8.6    |
| 2018-2020  | 101.0%  | 62.9%   | 81.0%   | 0.6  | 17.4   |
| 2019-2021  | 268.0%  | 62.9%   | 220.0%  | 0.6  | 27.5   |
| 2020-2022  | 239.0%  | 75.6%   | 237.0%  | 0.8  | 25.5   |
| 2021-2023  | -53.0%  | 77.5%   | -71.0%  | 0.6  | 17.0   |
| 2022-2024  | -200.0% | 77.5%   | -225.0% | 0.7  | 10.1   |
| 2023-2025  | -309.0% | 77.5%   | -360.0% | 3.0  | 9.8    |

**Analysis:**
*   **CAGR:**  Albemarle's annualized returns have varied significantly, from very high gains (e.g., 268% in 2019-2021) to substantial losses recently.
*   **MDD:**  Maximum Drawdown indicates significant volatility and potential for large losses.  Recent periods show high MDD values.
*   **Alpha:**  Alpha measures the stock's excess return compared to the benchmark.  The data indicates periods of significant outperformance (positive Alpha) followed by significant underperformance (negative Alpha), especially in recent years.
*   **Beta:**  Beta measures the stock's volatility relative to the market. Recent data indicates that stock is high Beta, so its price activity is strongly correlated with market.
*   **Cap:**  Company's capitalization

### 2. Recent Price Action

*   **Current Price:** $83.74
*   **Previous Close:** $84.18
*   **Price Change:** -$0.52
*   **5-Day Moving Average:** 81.42
*   **20-Day Moving Average:** 72.46
*   **60-Day Moving Average:** 63.73

**Analysis:**  The stock is currently trading above its 5, 20, and 60-day moving averages, suggesting an upward trend in the short to medium term.  The slight price decrease compared to the previous close is not a major concern on its own.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 73.77 (Approaching overbought territory)
*   **PPO:** 1.33 (Positive, indicating a potential uptrend)
*   **Hybrid Signal:** Buy 80% (Caution - MRI: 0.33)
*   **20-Day Relative Divergence Change:** +2.9 (Positive, indicating short-term upward momentum)
*   **Expected Return:** 1398.2% (Long-term, relative to S&P 500)

**Analysis:** The RSI approaching overbought, combined with PPO, and Hybrid Signal suggests that the stock might be overvalued.  The MRI indicating "Low Risk" suggests a less volatile market environment. A positive change in relative divergence indicates short-term upward momentum. The very high "Expected Return" should be viewed cautiously, as it represents a long-term projection with inherent uncertainties.

The recent price change of -$0.52 is relatively small and doesn't necessarily indicate a significant issue on its own.

### 4. Recent News & Significant Events

*   **2025-07-25:** Major business developments, regulatory changes, or market events.
*   **2025-07-26:** Analyst discussions of recent performance and outlook.
*   **2025-07-28:** Notable stock volatility.
*   **2025-07-24:** Market experts highlighting both risks and opportunities.

**Analysis:** The recent news suggests that Albemarle is experiencing significant events that are impacting its stock price. The volatility and analyst discussions indicate that the market is uncertain about the company's future prospects.

### 5. Recent Earnings Analysis:

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-04-30   | 0     | 1.08 B$   |
| 2024-11-06   | -9.45 | 1.35 B$   |
| 2024-07-31   | -1.96 | 1.43 B$   |
| 2024-05-01   | -0.08 | 1.36 B$   |
| 2025-04-30   | -0.08 | 1.36 B$   |

**Analysis:** The earnings per share (EPS) figures have been predominantly negative recently. The sales are experiencing a downward trend. These figures suggest underlying problems with the company's performance.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $1.08B   | 14.51%        |
| 2024-12-31   | $1.23B   | 11.22%        |
| 2024-09-30   | $1.35B   | -7.68%        |
| 2024-06-30   | $1.43B   | -0.74%        |
| 2024-03-31   | $1.36B   | 2.86%         |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-03-31   | $10.03B  | 0.41%    |
| 2024-12-31   | $9.96B   | 0.76%    |
| 2024-09-30   | $10.24B  | -10.44%   |
| 2024-06-30   | $11.22B  | -1.68%    |
| 2024-03-31   | $11.53B  | 0.02%    |

**Analysis:** Revenue has been declining. The profit margin has fluctuated significantly, with recent quarters showing negative values. Return on equity (ROE) has also been volatile, with a significant drop in recent quarters. The company's equity has also slightly declined.

### 7. Overall Summary

Albemarle Corp (ALB) has underperformed the S&P 500 significantly. Recent performance has been weak, with negative earnings per share and declining revenue. The stock price is showing an upward trend, but technical indicators suggest that it might be overbought. Recent news indicates market uncertainty about the company's prospects.

**Conclusion:**  Based on the provided data, a cautious approach to ALB is warranted.  While there are signs of short-term upward momentum, the company's fundamental performance and market sentiment raise concerns about its long-term prospects. Investors should carefully monitor the company's earnings, news, and technical indicators before making any investment decisions. The high Expected Return is speculative and should not be the sole basis for investment.
